Skip to main content

Table 1 Summary of clinical, histopathological and molecular genetic data of 25 tubular adenocarcinoma of stomach

From: Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?

Case No.

Age/sex

Histological type*

Invasion**

LN**

Stage **

CGH

p53 IHC

TP53mutation

M1

57/M

tub1

T1(M)

N0

IA

c/a

+

NT

M2

72/M

tub1

T1(M)

N0

IA

c/a

+

NT

M3

67/F

tub1

T1(M)

N0

IA

c/a

-

-

M4

67/M

tub1

T1(M)

N0

IA

c/a

-

-

M5

74/M

tub1

T1(M)

N0

IA

c/a

+

-

M6

65/M

tub1

T1(M)

N0

IA

c/a

+

-

M7

67/F

tub1

T1(M)

N0

IA

c/a

+

-

M8

70/F

tub1 > pap

T1(M)

N0

IA

c/a

-

-

M9

51/M

tub1 > tub2

T1(M)

N0

IA

c/a

+

-

M10

52/M

tub2

T1(M)

N0

IA

c/a

+

-

M11

57/F

tub2

T1(M)

N0

IA

NT/a

-

-

M12

89/M

tub2

T1(M)

N0

IA

NT/a

+

+

M13

70/M

tub1

T1(M)

N0

IA

NT/a

-

NA

S1m

73/F

tub2

T1(SM)

N0

IA

c/a

+

-

S1i

     

NT/a

+

-

S2m

81/F

pap

T1(SM)

N1

IB

c/a

+

-

S2i

     

NT/a

+

+

S3m

79/M

tub1

T1(SM)

N0

IA

c/a

+

+

S3i

     

NT/a

+

+

S4m

63/M

tub2 > tub1

T1(SM)

N0

IA

c/NT

+

NT

S5m

75/M

pap > tub2

T1(SM)

N1

IB

c/NT

+

NT

S6m

79/M

pap

T1(SM)

N1

IB

c/NT

+

NT

A1m

71/M

tub2

T2(SS)

N2

IIIA

c/a

null

-

A1i

     

NT/a

null

NA

A2m

73/M

tub1 > tub2

T2(SS)

N0

IB

c/a

+

-

A2i

     

NT/a

+

+

A3m

56/M

pap

T2(SS)

N1

II

c/a

+

-

A3i

     

NT/a

+

+

A4m

81/M

tub2/pap

T2(SS)

N2

IIIA

c/a

null

-

A4i

     

NT/a

null

+

A5m

56/M

tub1

T2(MP)

N0

IB

c/NT

-

NT

A5i

     

NT/NA

-

NA

A6m

45/F

tub2

T2(SS)

N1

IB

c/NT

+

NT

A7m

79/F

tub2

T2(MP)

N1

IB

c/NT

+/-

NT

A8m

69/M

tub1

T3(SE)

N2

IIIB

c/a

null

-

A8i

     

NT/a

null

NA

A9m

67/F

tub2

T2(SS)

N1

II

c/a

+

-

A9i

     

NT/a

+

+

  1. * Japanese classification of gastric carcinoma; ** pTNM classification. In the column of Case No, M = intramucosal cancer; S = cancer involving the submucosa; A = advanced cancer; m = mucosal part; i = invasive part. In the column of CGH, c = chromosomal CGH; a = array CGH. In the column of p53 immunohistochemistry (IHC); "+" indicates diffusely (>70%) positive nuclei, "-" indicates sporadically (<5%) positive nuclei; "null" indicates no immunoreactivity at all. In the column of TP53 mutation; "+" and "-" indicate presence and absence of mutation, respectively; NA = not assessable; NT = not tested.